Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
AIDS Research and Human Retroviruses|August 27, 2013
Virological and immunological response to antiretroviral regimens containing maraviroc in HIV type 1-infected patients in clinical practice: role of different tropism testing results and of concomitant treatmentsBarbara Rossetti, Claudia Bianco, Lara Ines Bellazzi, et al.
Studies in Health Technology and Informatics|May 21, 2015
IANUA: a regional project for the determination of costs in HIV-infected patientsBarbara Giannini, Roberta Gazzarata, Patrizia Orcamo, et al.
Human Immunology|February 19, 2004
Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL functionGilberto Filaci, Marco Fravega, Simone Negrini, et al.
AIDS Care|November 11, 2020
Long-term maintenance of virologic suppression in native and migrant HIV-1 naïve patients: an Italian cohort studyFilippo Lagi, Seble Tekle Kiros, Simona Di Giambenedetto, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 3, 2013
Natural killer cells in HIV controller patients express an activated effector phenotype and do not up-regulate NKp44 on IL-2 stimulationFrancesco Marras, Elena Nicco, Federica Bozzano, et al.
The New Microbiologica|October 21, 2015
Genetic polymorphisms of IL28b gene as predictors of response to dual therapy in genotypes 1 and 4-HCV and HIV/HCV-infected patientsLaura Sticchi, Antonio Di Biagio, Marina Sartini, et al.
Human Immunology|January 1, 2003
Apoptotic DNA binds to HLA class II molecules inhibiting antigen presentation and participating in the development of anti-inflammatory functional behavior of phagocytic macrophagesGilberto Filaci, Paola Contini, Marco Fravega, et al.
Cancer Immunology, Immunotherapy : CII|April 18, 2013
A multi-peptide, dual-adjuvant telomerase vaccine (GX301) is highly immunogenic in patients with prostate and renal cancerDaniela Fenoglio, Paolo Traverso, Alessia Parodi, et al.
Blood|October 27, 2005
Frequency of telomerase-specific CD8+ T lymphocytes in patients with cancerGilberto Filaci, Marco Fravega, Maurizio Setti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2007
CD8+ CD28- T regulatory lymphocytes inhibiting T cell proliferative and cytotoxic functions infiltrate human cancersGilberto Filaci, Daniela Fenoglio, Marco Fravega, et al.
Pageof 3